Table 2 Cardiac PET/CT and echocardiography measurements
Overall, N = 901 | Men, N = 635 | Women, N = 266 | P-value | |
|---|---|---|---|---|
MFR | 2.55 ± 0.73 | 2.59 ± 0.77 | 2.44 ± 0.61 | 0.003 |
MFR < 2, n (%) | 197 (21.9) | 134 (21.1) | 63 (23.7) | 0.40 |
MFR < 1.7, n (%) | 93 (10.3) | 69 (10.9) | 24 (9.0) | 0.40 |
RPP corrected MFR | 2.74 ± 0.81 | 2.76 ± 0.87 | 2.69 ± 0.67 | 0.30 |
MBF rest ml/min/g | 1.21 ± 0.34 | 1.12 ± 0.31 | 1.42 ± 0.32 | < 0.001 |
RPP corrected MBF rest ml/min/g | 1.11 ± 0.28 | 1.04 ± 0.24 | 1.28 ± 0.28 | < 0.001 |
MBF stress ml/min/g | 2.92 ± 0.72 | 2.76 ± 0.70 | 3.30 ± 0.60 | < 0.001 |
CACS | 138 (13, 601) | 209 (30, 800) | 53 (1, 280) | < 0.001 |
CACS, n (%) | < 0.001 | |||
0 | 121 (13.7) | 62 (10.0) | 59 (22.4) | |
1–99 | 278 (31.5) | 182 (29.4) | 96 (36.5) | |
100–399 | 188 (21.3) | 135 (21.8) | 53 (20.2) | |
> 400 | 296 (33.5) | 241 (38.9) | 55 (20.9) | |
LVEF at rest (%) | 66 ± 8 | 64 ± 8 | 72 ± 7 | < 0.001 |
LVEF at stress (%) | 72 ± 8 | 69 ± 8 | 78 ± 7 | < 0.001 |
LVEF-reserve | 5 ± 4 | 5 ± 4 | 5 ± 4 | 0.70 |
RPP at rest | 9,409 ± 1,968 | 9,316 ± 1,944 | 9,629 ± 2,011 | 0.027 |
RPP at stress | 10,897 ± 2,439 | 10,572 ± 2,377 | 11,676 ± 2,413 | < 0.001 |
LVEF from echocardiogram | 55 ± 6 | 54 ± 7 | 57 ± 5 | < 0.001 |
GLS from echocardiogram | 16.3 ± 2.7 | 16.0 ± 2.8 | 17.0 ± 2.2 | < 0.001 |
Reversible perfusion defect (≥ 5%), n (%) | 239 (26.5) | 193 (30.4) | 46 (17.3) | < 0.001 |
Eversible perfusion defect, (extent %)* | 7.0 (5.0, 11.0) | 7.0 (5.0, 11.0) | 7.0 (5.0, 9.8) | 0.60 |
Irreversible perfusion defect (≥ 5%), n (%) | 19 (2.1) | 17 (2.7) | 2 (0.8) | 0.067 |
Irreversible perfusion defect (extent %)† | 6.0 (5.0, 8.0) | 6.0 (5.0, 8.0) | 5.5 (5.3, 5.8) | 0.50 |